The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial

Aim: Malondialdehyde-modified low-density lipoprotein (MDA-LDL) forms a significant component of oxidised LDL. The effects of exercise on levels of MDA-LDL and anti-MDA-LDL antibodies are not well-understood. Furthermore, it is not known whether these can be modified in patients with coronary artery...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartley, Adam, Shun-Shin, Matthew, Caga-Anan, Mikhail, Rajkumar, Christopher, Nowbar, Alexandra N., Foley, Michael, Francis, Darrel P., Haskard, Dorian O., Khamis, Ramzi Y., Al-Lamee, Rasha K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542769/
https://www.ncbi.nlm.nih.gov/pubmed/34708098
http://dx.doi.org/10.3389/fcvm.2021.757030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542769/
https://www.ncbi.nlm.nih.gov/pubmed/34708098
http://dx.doi.org/10.3389/fcvm.2021.757030

Ejemplares similares